Alao, Lanie C.

HRN: 28-65-70  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/03/2026
03/04/2026
IV
900 Mg
Q8
Thickly MSAF
Remove - Pending Acceptance
03/03/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
03/03/2026
03/04/2026
IV
20 Mg
OD
Thickly MSAF, Transient Uterine Atony
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: